Skip to main content
Log in

Dual Antiplatelet Therapy Does Not Increase Bleeding Risk in Percutaneous Gastrostomy Tube Placement: Network Meta-Analysis

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

An Invited Commentary to this article was published on 17 March 2023

Abstract

Background/Objective

Gastrostomy tube (G tube) is a commonly performed procedure for nutritional support. Current guidelines recommend discontinuation of dual antiplatelet therapy (DAPT) prior to G tube placement to reduce bleeding risk.

Aims

We aim to compare bleeding risk in single, dual and no antiplatelet therapy during G tube placement.

Methods

We searched PubMed, Embase, Cochrane, and Web of Sciences to include comparative studies evaluating single antiplatelet (aspirin, clopidogrel), dual antiplatelet (DAPT, aspirin and clopidogrel), and no antiplatelet therapy. Direct as well as network meta-analyses comparing these arms were performed. Risk Differences (RD) with confidence intervals were calculated.

Results

12 studies with 8471 patients were included. On direct meta-analysis, there was no significant difference noted between DAPT compared to Aspirin (RD 0.001 95% CI − 0.012 to 0.014, p = 0.87), Clopidogrel (RD 0.001 95% CI − 0.009 to 0.010, p = 0.92) or no antiplatelet group (RD 0.007 95% CI − 0.011 to 0.026, p = 0.44).

Results were consistent on network meta-analysis and no difference was noted in bleeding rates when comparing DAPT with Aspirin (RD 0.001, 95% CI − 0.007 to 0.01, p = 0.76), Clopidogrel (RD 0.001, 95% CI − 0.01 to 0.011, p = 0.90) and no antiplatelet group (RD 0.002, 95% CI − 0.007 to 0.012, p = 0.62).

Conclusion

There is no significant difference in bleeding risk between DAPT, single antiplatelet or no antiplatelet therapy on a population level. On an individual level, risk of ischemic events should be weighed against the risk of bleeding based on patient circumstances and risk profile. Our findings offer to provide additional data to make an informed decision between patients and physicians to make clinical decisions by assessing individual risks and benefits for optimal care of complex patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

G tube:

Gastrostomy tube (endoscopically or radiologically)

PEG:

Percutaneous endoscopic gastrostomy

DAPT:

Dual antiplatelet therapy

GI:

Gasto-intestinal

SAPT:

Single antiplatelet therapy

RD:

Risk difference

RIG:

Radiologically inserted G tube

NACE:

Net adverse clinical events

MACE:

Major adverse cardiovascular events

CVA:

Cerebrovascular accident

References

  1. Molina Villalba C, Vázquez Rodríguez J, Gallardo Sánchez F. Gastrostomía endoscópica percutánea. Indicaciones, cuidados y complicaciones. Medicina Clínica 2019;152:229–236.

    Article  PubMed  Google Scholar 

  2. Lucendo A, Sánchez-Casanueva T, Redondo O, Tenías J, Arias Á. Risk of bleeding in patients undergoing percutaneous endoscopic gastrotrostomy (PEG) tube insertion under antiplatelet therapy: a systematic review with a meta-analysis. Revista Española de Enfermedades Digestivas 2015;107:128–136.

    CAS  PubMed  Google Scholar 

  3. Page M, Moher D, Bossuyt P, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;n160.

  4. https://handbook-5-1.cochrane.org/chapter_9/9_4_3_a_generic_inverse_variance_approach_to_meta_analysis.htm

  5. Nisbet R, Elder J, Miner G. Data Understanding and Preparation. Handbook of Statistical Analysis and Data Mining Applications, 2009: 49–75.

  6. https://handbook-5-1.cochrane.org/chapter_9/9_5_2_identifying_and_measuring_heterogeneity.htm

  7. https://training.cochrane.org/handbook/current/chapter-11#section-11-4-4

  8. https://gdt.gradepro.org/app/handbook/handbook.html

  9. https://handbook-5-1.cochrane.org/chapter_13/13_5_2_3_tools_for_assessing_methodological_quality_or_risk_of.html

  10. Thosani N, Rashtak S, Kannadath B et al. Bleeding risk and mortality associated with uninterrupted antithrombotic therapy during percutaneous endoscopic gastrostomy tube placement. Am J Gastroenterol 2021;116:1868–1875.

    Article  CAS  PubMed  Google Scholar 

  11. Tramel R, Sandow T, April D, Ramalingam V. Safety and feasibility of percutaneous gastrostomy placement in patients on antiplatelet therapy. Ochsner J 2021;21:158–162.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Eventscribe.net. 2022. ACG 2020 ePoster Hall. https://www.eventscribe.net/2020/ACGPosters/fsPopup.asp?efp=RE5YS1FTRkIxMTY4Nw&PosterID=298414&rnd=0.6197251&mode=posterinfo. Accessed 28 April 2022.

  13. Haddad P, Kannadath B, Munjal A et al. Mo1321 peg tube can be successfully placed in patients on uninterrupted dual-antiplatelet therapy without any complications: time to change clinical practice. Gastrointest Endosc 2019;89:AB490.

    Article  Google Scholar 

  14. Chandrala C, Badipatla K, Vupputuri A, Nayudu S, Chilimuri S. Mo1205 Bleeding complications associated with percutaneous endoscopic gastrostomy in the setting of antithrombotic agents. Gastrointest Endosc 2017;85:AB461–AB462.

    Article  Google Scholar 

  15. Kannadath B, Khurana S, Bhandari B et al. Percutaneous Endoscopic Gastrostomy (PEG) tubes can be safely placed in geriatric patients on uninterrupted Dual Anti-Platelet Therapy (DAPT). Am J Gastroenterol 2022;112:S684.

    Article  Google Scholar 

  16. Lee C, Im J, Kim J et al. Risk factors for complications and mortality of percutaneous endoscopic gastrostomy: a multicenter, retrospective study. Surg Endosc 2013;27:3806–3815.

    Article  PubMed  Google Scholar 

  17. Thosani N, Nevah M, Khanijow V et al. Sa1683 Bleeding risk associated with continuing antiplatelet therapy during PEG tube placement: should we throw caution to the wind? Gastrointest Endosc 2012;75:243.

    Article  Google Scholar 

  18. Lozoya-González D, Pelaez-Luna M, Farca-Belsaguy A, Salceda-Otero J, Vazquéz-Ballesteros E. Percutaneous endoscopic gastrostomy complication rates and compliance with the american society for gastrointestinal endoscopy guidelines for the management of antithrombotic therapy. J Parenteral Enteral Nutr 2011;36:226–230.

    Article  Google Scholar 

  19. Singh D, Laya A, Vaidya O, Ahmed S, Bonham A, Clarkston W. Risk of Bleeding After Percutaneous Endoscopic Gastrostomy (PEG). Dig Dis Sci 2011;57:973–980. https://doi.org/10.1007/s10620-011-1965-7.

    Article  PubMed  Google Scholar 

  20. Bal B, Karim A, Olden K. Percutaneous endoscopic gastrostomy placement: do we need to stop the antiplatelet therapy? Gastrointest Endosc 2011;73:AB226.

    Article  Google Scholar 

  21. Ruthmann O, Seitz A, Richter S et al. Perkutane endoskopische Gastrostomie. Der Chirurg 2009;81:247–254.

    Article  Google Scholar 

  22. Schrag S, Sharma R, Jaik N et al. Complications related to Percutaneous Endoscopic Gastrostomy (PEG) tubes. A comprehensive clinical review. J Gastrointest Liver Dis 2007;16:407–418.

    Google Scholar 

Download references

Funding

No funding was received for the preparation of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Manesh Kumar Gangwani.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Research involving human and animal rights

No human subjects/animals were involved in this systematic review and meta-analysis.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

An editorial commenting on this article is available at https://doi.org/10.1007/s10620-023-07878-5.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 67 kb)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gangwani, M.K., Aziz, M., Aziz, A. et al. Dual Antiplatelet Therapy Does Not Increase Bleeding Risk in Percutaneous Gastrostomy Tube Placement: Network Meta-Analysis. Dig Dis Sci 68, 1966–1974 (2023). https://doi.org/10.1007/s10620-022-07804-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-022-07804-1

Keywords

Navigation